Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages 3515-3521

  Tomisti, Luca ^a   Materazzi, Gabriele ^a   Bartalena, Luigi ^b   Rossi, Giuseppe ^c   Marchello, Angelica ^a   Moretti, Manuela ^a   De Napoli, Luigi ^a   Mariotti, Rita ^a   Miccoli, Paolo ^a   Martino, Enio ^a   Bogazzi, Fausto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOCORTICOID; IOPANOIC ACID; LEVOTHYROXINE; LIOTHYRONINE; POTASSIUM PERCHLORATE; SOTALOL; THIONAMIDE DERIVATIVE; THYROXINE;

ACUTE HEART INFARCTION; ADULT; AMIODARONE INDUCED THYROTOXICOSIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; EUTHYROIDISM; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOPARATHYROIDISM; ITALY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE INJURY; RETROSPECTIVE STUDY; RISK REDUCTION; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; THYROID FUNCTION TEST; THYROIDECTOMY; THYROTOXICOSIS; UNSPECIFIED SIDE EFFECT;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SYSTOLE; THYROIDECTOMY; THYROTOXICOSIS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84867272318     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1797     Document Type: Article

References (26)

1. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254 (Pubitemid 32458161)
2. Eskes SA, Wiersinga WM 2009 Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23:735-751
3. Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E 2001 The various effects of amiodarone on thyroid function. Thyroid 11:511-519 (Pubitemid 32494600)
4. Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E 2012 Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 35:340-348
5. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E 2007 Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92:556-562
6. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E 1996 Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930-2933 (Pubitemid 26323888)
7. O'Sullivan AJ, Lewis M, Diamond T 2006 Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol 154:533-536
8. Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B, Sticherling C, Muller B, Osswald S 2007 Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol 49:2350-2355 (Pubitemid 46891714)
9. Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, Shea YF, Fan K, Tse HF, Chow WH 2009 Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab 94:109-114
10. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS 2003 Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108:977-982 (Pubitemid 37048228)
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463 (Pubitemid 41821197)
12. Bogazzi F, Tomisti L, Rossi G, Dell'Unto E, Pepe P, Bartalena L, Martino E 2009 Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J Clin Endocrinol Metab 94:3757-3762
13. Bogazzi F, Bartalena L, Vitti P, Rago T, Brogioni S, Martino E 1996 Color flow Doppler sonography in thyrotoxicosis factitia. J Endocrinol Invest 19:603-606 (Pubitemid 26408102)
14. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini- Lombardi F, Ceccarelli C, Pinchera A, Bartalena L, Braverman LE 2003 Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest 26:635-640
15. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E 1997 Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7:541-545 (Pubitemid 27371790)
16. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E 2004 Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61:494-502 (Pubitemid 39388489)
17. Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM 2006 Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65:433-438 (Pubitemid 44414265)
18. Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L 2008 Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69:812-818
19. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E 2007 Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol (Oxf) 67:533-537 (Pubitemid 47416310)
20. Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE 1990 Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263:1526-1528 (Pubitemid 20099048)
21. Gough J, Gough IR 2006 Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 30:1957-1961 (Pubitemid 44655798)
22. Franzese CB, Fan CY, Stack Jr BC 2003 Surgical management of amiodarone-induced thyrotoxicosis. Otolaryngol Head Neck Surg 129:565-570 (Pubitemid 37377588)
23. Houghton SG, Farley DR, Brennan MD, van Heerden JA, Thompson GB, Grant CS 2004 Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg 28: 1083-1087 (Pubitemid 40109855)
24. Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda ML, Miccoli P, Basolo F, Pinchera A, Bartalena L, Braverman LE, Martino E 2002 Iopanoic acid rapidly controls type I amiodaroneinduced thyrotoxicosis prior to thyroidectomy. J Endocrinol Invest 25:176-180 (Pubitemid 34232620)
25. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE, Martino E 2002 Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114-1118 (Pubitemid 36026963)
26. Ahmed S, Van Gelder IC, Wiesfeld ACP, Van Veldhuisen DJ, Links TP 2011 Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol (Oxf) 75:388-394